New therapeutic targets for the treatmen
β
Lars M. Wagner; Mary K. Danks
π
Article
π
2009
π
John Wiley and Sons
π
English
β 146 KB
## Abstract Highβrisk neuroblastoma remains a major problem in pediatric oncology, accounting for 15% of childhood cancer deaths. Although incremental improvements in outcome have been achieved with the intensification of conventional chemotherapy agents and the addition of 13β__cis__βretinoic acid